POLYTHIAZIDE (200 MG)

POLYTHIAZIDE (200 MG) Basic information
Product Name:POLYTHIAZIDE (200 MG)
Synonyms:2h-1,2,4-benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-2-methyl-3-(((2,2;2h-benzo-1,2,4-thiadiazine1,1-dioxide;2-methyl-3-(beta,beta,beta-trifluoroethylthiomethyl)-6-chloro-7-sulfamyl-3,4-d;6-Chloro-2-methyl-3-([(2,2,2-trifluoroethyl)sulfanyl]methyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide;6-Chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide;6-Chloro-3,4-dihydro-2-methyl-3-[[(2,2,2-trifluoromethyl)thio]methyl]-2H-1,2,4-benzothiadiazine -7-sulfonamide 1,1-dioxide;benzothiadiazine-7-sulfonamide1,1-dioxide;Drenusil
CAS:346-18-9
MF:C11H13ClF3N3O4S3
MW:439.8818296
EINECS:2064684
Product Categories:
Mol File:346-18-9.mol
POLYTHIAZIDE (200 MG) Structure
POLYTHIAZIDE (200 MG) Chemical Properties
Melting point 202.5°
Boiling point 580.1±60.0 °C(Predicted)
density 1.8346 (rough estimate)
refractive index 1.6100 (estimate)
storage temp. Refrigerator
solubility DMSO (Slightly), Methanol (Slightly, Heated)
pkapKa 9.58(H2O,t =25) (Uncertain)
form Solid
color White to Off-White
EPA Substance Registry SystemPolythiazide (346-18-9)
Safety Information
Hazardous Substances Data346-18-9(Hazardous Substances Data)
MSDS Information
POLYTHIAZIDE (200 MG) Usage And Synthesis
DescriptionPolythiazide exhibits a more pronounced antihypertensive effect than chlorothiazide and it may be used independently for the same indications as the aforementioned drugs. However, it is primarily used as an ingredient of a combination drugs intended for lowering pressure, in particular in minizide, which is a combination of prazozine and polythiazide.
OriginatorRenese ,Pfizer, US ,1961
UsesPolythiazide is a thiazide diuretic. Polythiazide is used in the treatment of hypertension as well as nephrotic syndrome, cirrhosis of the liver, and nutritional edema.
DefinitionChEBI: Polythiazide is a benzothiadiazine.
Manufacturing Process(A) Preparation of trifluoroethylthioacetaldehyde dimethylacetal: To 4.6 g (0.2 mol) of metallic sodium dissolved in 75 ml of absolute methanol is rapidly added 24.4 g (0.2 mol) of mercaptoacetaldehyde dimethylacetal followed by dropwise addition of 42.0 g (0.2 mol) of trifluoroethyl iodide.
The resulting reddish mixture is refluxed on a steam bath for one hour. One half of the alcohol is removed by concentration and the remainder diluted with several volumes of water and extracted with ether. The combined ether extracts are dried over sodium sulfate, the ether then removed at reduced pressure and the residue distilled to about 30 g (BP 82°C/25 mm).
(B) Preparation of 4-Amino-2-Chloro-5-(Methylsulfamyl)Benzenesulfonamide: The 5-substituted-2,4-disulfamyl anilines may be prepared by procedures described in the literature, for example, the general procedures in Monatsch. Chem. vol. 48, p 87 (1927), which involves the treatment of a m-substituted aniline with from 10 to 20 parts by weight of chlorosulfonic acid followed by the gradual addition of from about 90 to 170 parts by weight of sodium chloride. The resultant mixture is heated at approximately 150°C for about 2hours after which the reaction mixture is poured into water and the resultant 5substituted aniline-2,4-disulfonyl chloride is filtered and is then treated with concentrated ammonium hydroxide or suitable amine by standard procedures to obtain the corresponding disulfonamide.
(C) Preparation of 2-Methyl-3-(2,2,2-Trifluoroethyl)Thiomethyl-6-Chloro-7Sulfamyl-3,4-Dihydro-1,2,4-Benzothiadiazine-1,1-Dioxide: To 4.6 g (0.015 mol) of 4-amino-2-chloro5-(methylsulfamyl)benzenesulfonamide in 30 ml of the dimethyl ether of ethylene glycol is added 4.08 g (0.02 mol) of 2,2,2trifluoroethylmercaptoacetaldehyde dimethylacetal followed by 1 ml of ethyl acetate saturated with hydrogen chloride gas. The resulting solution is refluxed for 1.5 hours, cooled and then slowly added to cold water dropwise with stirring. The crude product is filtered, dried and recrystallized from isopropanol (3.2 g), MP 202° to 202.5°C. A second recrystallization from isopropanol raised the MP to 202° to 203°C.


Brand nameRenese (Pfizer).
Therapeutic FunctionDiuretic
General DescriptionCrystals or white powder.
Air & Water ReactionsIts rate of decomposition in solution increases with an increase in pH. . Insoluble in water.
Reactivity ProfilePOLYTHIAZIDE (200 MG) is a sulfonamide derivative. With strong reducing agents will produce hydrogen sulfide gas.
Fire HazardFlash point data for POLYTHIAZIDE (200 MG) are not available, but POLYTHIAZIDE (200 MG) is probably combustible.
SynthesisPolythiazide, 1,1-dioxide 2-methyl-3-(2,2,2-trifluoroethylthiomethyl)-6- chloro-3,4-dihydro-2H-1,2,4-benzothiadiazin-7-sulfonamide (21.3.8), is also synthesized by an analogous scheme, which is by condensing 4-aminosulfonyl-5-chloro-2-methylaminosulfonylaniline (21.3.7) with 2,2,2-trifluoroethylthioacetaldehyde dimethylacetal.

Synthesis_346-18-9

Bumetanide Benzenesulfonamide, 2-(methylamino)- (9CI) 2-AMINO-N-METHYLBENZENESULFONAMIDE 4-Chloro-N-methylbenzenesulphonamide 2,2,2-TRIFLUOROETHANETHIOL 4-CHLORO-1,3-BENZENEDITHIOL POLYTHIAZIDE (200 MG) CLOFENAMIDE o-Chlorobenzenesulfonamide Hydrochlorothiazide 2-amino-N,N-dimethylbenzenesulfonamide Flurese 4-Amino-6-chlorobenzene-1,3-disulfonamide 2-Aminobenzenesulfonamide

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.